PD Neurotechnology, a MedTech start-up for patients suffering from Parkinson’s Disease, is targeting €500.000

246

PD Neurotechnology, a MedTech start-up for patients suffering from Parkinson’s Disease, the second most common neurologic disease in the world, is targeting €500.000 in the financing round opened by SeedBlink, the European co-investment platform in tech startups.   This €5.000,000 Series A round is led by CIC Capital Partners, the co-investment from CIC Capital Partners […]

The post PD Neurotechnology, a MedTech start-up for patients suffering from Parkinson’s Disease, is targeting €500.000 appeared first on Business Review.

Read the full post on Business-Review.eu.